An urgent warning echoed across labs and clinics: protecting newborns from the common respiratory syncytial virus (RSV) may prevent asthma later in childhood. A groundbreaking Danish study found that babies hospitalized with RSV infections are about three times more likely to be diagnosed with asthma, with the risk rising higher when parents have allergies. This suggests that a single viral hit in the first weeks of life can reshape respiratory health for years to come. The findings, published in Science Immunology, emphasize the window of vulnerability in early life and how early insults can cascade into lifelong outcomes.
RSV is typically mild in many infants, but it remains a major cause of hospitalization for children under five in Europe, including roughly 213,000 hospitalizations per year in the EU, Norway, and the United Kingdom. Across the EU, about 5.7% of residents have asthma, with notable country variation—from 1.5% in Romania to 9.4% in Finland. The study combines population data with controlled lab experiments to reveal how early viral infections trigger immune changes, increasing sensitivity to common allergens such as house dust mites. In mouse models, researchers observed that viral infection can prime the immune system, while maternal allergy antibodies may transfer to babies, further elevating risk.
A key implication is that preventing RSV infection in infancy could reduce asthma risk, yielding enormous benefits for families and health systems. In 2023, the European Union approved the first RSV vaccine to protect babies up to six months old. Maternal immunization—vaccinating women during pregnancy—produces antibodies that cross the placenta, offering newborns early protection. However, uptake varies by country, and public-health campaigns are needed to translate this short-term shield into long-term respiratory health.
Protective strategies matter most in the earliest weeks of life. Parents should discuss RSV vaccination with their healthcare providers, especially during pregnancy or in the newborn period, where policy and paediatric practice can work together to maximize protection. Health systems can focus on expanding access, increasing awareness among expectant mothers, and ensuring that pediatricians highlight RSV prevention as part of newborn care.
In Romania, where asthma prevalence sits around 1.5%, the potential impact of improved RSV prevention could be substantial if uptake is expanded. Meanwhile, countries with higher asthma rates may see even larger benefits from broad vaccination campaigns and robust prenatal programs.